BETA
Your AI-Trained Oncology Knowledge Connection!
George Shares Takeaways From IO Trials and AE Management in Pretreated RCC
During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell carcinoma who received prior immune checkpoint inhibitor.
